Xiao Q, Tang H, Kong L, Ji H, Liu Y, Cui G

Idioma: Ingles.
Referencias bibliográficas: 23
Paginas: 116-123
Archivo PDF: 550.45 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Heck CN, King-Stephens D, Massey AD, et al. Two-year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS system pivotal trial. Epilepsia. 2014;55: 432-41.

2. Nascimento FP, Macedo-Júnior SJ, Pamplona FA, et al. Adenosine A1 receptor-dependent antinociception induced by inosine in mice: pharmacological, genetic and biochemical aspects. Mol Neurobiol. 2015;51:1368-78.

3. Dennissen FJ, Anglada-Huguet M, Sydow A, Mandelkow E, Mandelkow EM. Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human tau ΔK280. Proc Natl Acad Sci U S A. 2016;113:11597-602.

4. Rivera-Oliver M, Díaz-Ríos M. Using caffeine and other adenosine receptor antagonists and agonists as therapeutic tools against neurodegenerative diseases: a review. Life Sci. 2014; 101:1-9.

5. Hohoff C, Garibotto V, Elmenhorst D, et al. Association of adenosine receptor gene polymorphisms and in vivo adenosine A1 receptor binding in the human brain. Neuropsychopharmacology. 2014;39:2989-99.

6. Serpa A, Correia S, Ribeiro JA, Sebastião AM, Cascalheira JF. The combined inhibitory effect of the adenosine A1 and cannabinoid CB1 receptors on cAMP accumulation in the hippocampus is additive and independent of A1 receptor desensitization. BioMed Res Int. 2015;2015:872684.

7. Thomas TP, Shih TM. The Use of Adenosine Agonists to Treat Nerve Agent-Induced Seizure and Neuropathology. United States: US Army Medical Research Institute of Chemical Defense Aberdeen Proving Ground United States; 2016.

8. Stockwell J, Jakova E, Cayabyab FS. Adenosine A1 and A2A receptors in the brain: current research and their role in neurodegeneration. Molecules. 2017;22:E676.

9. Cheng P, Ren Y, Bai S, et al. Chronic cerebral ischemia induces downregulation of A1 adenosine receptors during white matter damage in adult mice. Cell Mol Neurobiol. 2015;35:1149-56.

10. Hu J, Quick MW. Substrate-mediated regulation of gammaaminobutyric acid transporter 1 in rat brain. Neuropharmacology. 2008;54:309-18.

11. Stubbs B, Vancampfort D, Rosenbaum S, et al. An examination of the anxiolytic effects of exercise for people with anxiety and stress-related disorders: a meta-analysis. Psychiatry Res. 2017; 249:102-8.

12. Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 1972;32:281-94.

13. Zhong M, Song WL, Xu YC, Ye Y, Feng LY. Paeoniflorin ameliorates ischemic neuronal damage in vitro via adenosine A1 receptor- mediated transactivation of epidermal growth factor receptor. Acta Pharmacol Sin. 2015;36:298-310.

14. EuroEPINOMICS-RES Consortium, Epilepsy Phenome/Genome Project, Epi4K Consortium. De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. Am J Hum Genet. 2014;95:360-70.

15. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475-82.

16. Yin D, Liu YY, Wang TX, et al. Paeoniflorin exerts analgesic and hypnotic effects via adenosine A1 receptors in a mouse neuropathic pain model. Psychopharmacology (Berl). 2016;233: 281-93.

17. Liu XH, Xiang SJ, Qi Y. Histopathological changes of hippocampus after acute epilepsy induced by pentylenetetrazole in rats. Chin Pharmacol Bull. 2015;31:514-8.

18. André V, Dubé C, François J, et al. Pathogenesis and pharmacology of epilepsy in the lithium-pilocarpine model. Epilepsia. 2007; 48 Suppl 5:41-7.

19. Hanaya R, Sasa M, Sugata S, et al. Hippocampal cell loss and propagation of abnormal discharges accompanied with the expression of tonic convulsion in the spontaneously epileptic rat. Brain Res. 2010;1328:171-80.

20. Patel HC, Ross FM, Heenan LE, et al. Neurodegenerative actions of interleukin-1 in the rat brain are mediated through increases in seizure activity. J Neurosci Res. 2006;83:385-91.

21. Tan Z, Sankar R, Shin D, et al. Differential induction of p53 in immature and adult rat brain following lithium-pilocarpine status epilepticus. Brain Res. 2002;928:187-93.

22. Faherty CJ, Xanthoudakis S, Smeyne RJ. Caspase-3-dependent neuronal death in the hippocampus following kainic acid treatment. Brain Res Mol Brain Res. 1999;70:159-63.

23. Reid CA, Kim T, Phillips AM, et al. Multiple molecular mechanisms for a single GABAA mutation in epilepsy. Neurology. 2013;80:1003-8.